• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    The Cigna Group announces leadership changes to continue driving growth

    1/17/24 9:15:00 AM ET
    $CI
    Medical Specialities
    Health Care
    Get the next $CI alert in real time by email
    • Brian Evanko to continue as Chief Financial Officer, will serve as new President and CEO of Cigna Healthcare
    • Ann Dennison to join The Cigna Group as Deputy Chief Financial Officer
    • Mike Triplett to retire by end of 2024 and Bryan Holgerson promoted to President of U.S. Commercial for Cigna Healthcare
    • Eric Palmer to assume expanded role leading enterprise strategy and corporate development, will continue as President and CEO of Evernorth Health Services

    BLOOMFIELD, Conn., Jan. 17, 2024 /PRNewswire/ -- The Cigna Group (NYSE:CI), a global health company, today announced leadership changes designed to continue accelerating growth across Evernorth Health Services and Cigna Healthcare.

    The Cigna Group (PRNewsfoto/The Cigna Group)

    "Brian and Eric are experienced leaders whose depth of knowledge of both our enterprise and our industry will allow us to capitalize on the strengths of our foundational businesses while generating scale in our accelerated businesses," said David M. Cordani, chairman and chief executive officer, The Cigna Group. "With them at the helm of our two growth platforms, alongside their seasoned leadership teams, we believe we are well positioned to deliver on our strategy with clarity and purpose."

    Brian Evanko to continue as Chief Financial Officer for The Cigna Group, and assume expanded role as President and Chief Executive Officer, Cigna Healthcare

    Brian Evanko will continue to serve as Chief Financial Officer for The Cigna Group and assume the new role of President and Chief Executive Officer for Cigna Healthcare. He will oversee all Cigna Healthcare businesses, including U.S. Commercial, International Health, and U.S. Government. Evanko joined Cigna in 1998 and has held several business and financial leadership roles over the course of his tenure, including oversight of the U.S. Government business. During his time as CFO, the company has delivered against its earnings objectives.

    Ann Dennison joins The Cigna Group as Deputy Chief Financial Officer

    Ann Dennison will join The Cigna Group as Deputy Chief Financial Officer. Previously, she was an Executive Vice President and the Chief Financial Officer at Nasdaq, where she led a global team responsible for corporate finance, treasury, planning and analysis, investor relations, ESG reporting, procurement and real estate. Dennison joined Nasdaq in 2015 as Senior Vice President, Controller and Chief Accounting Officer, and prior to that, she was a Managing Director and Head of Financial Reporting at Goldman Sachs. Dennison holds a BBA/MBA in Accounting and Finance from Pace University's Lubin School of Business.

    Mike Triplett to retire by end of 2024; Bryan Holgerson named President, U.S. Commercial, Cigna Healthcare

    Current U.S. Commercial President Mike Triplett will retire by the end of 2024. During his tenure, he has overseen growth for the commercial business and drove Cigna Healthcare's work with network hospitals, facilities, and clinicians to improve affordability and enhance quality. As part of the transition plan, he will assume the role of special advisor to the CEO where he will focus on solutions for key distribution channels.

    Bryan Holgerson will be promoted to serve as President of U.S. Commercial for Cigna Healthcare. During his more than 22 years with the company, Holgerson has gained deep experience shaping and executing business growth strategies across a diverse portfolio. Prior to his current role leading U.S. Commercial National Accounts and the Underwriting team, Holgerson served as a Market President and held key leadership positions in National Accounts, among other senior roles.

    Dennison and Holgerson will report to Evanko.

    Eric Palmer to assume expanded role as Executive Vice President for Enterprise Strategy, The Cigna Group, and continue as President and Chief Executive Officer, Evernorth Health Services

    Eric Palmer will expand his role to assume oversight of The Cigna Group Enterprise Strategy and Corporate Development, in addition to continuing to serve as President and Chief Executive Officer, Evernorth Health Services. He will be responsible for mapping long-term growth strategies, further growing the enterprise's health services businesses through M&A activity and fueling innovation through Cigna Ventures. Over the course of his 26-year career with Cigna, Palmer has held many business and financial leadership positions, including serving as CFO from 2017 through 2020. Since assuming his current role leading Evernorth, the business has significantly grown while expanding its services offerings and innovating new capabilities. 

    About The Cigna Group:

    The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services marketed under Evernorth Health Services, Cigna Healthcare, or its subsidiaries. The Cigna Group maintains sales capabilities in more than 30 countries and jurisdictions, and has more than 165 million customer relationships around the world. Learn more at thecignagroup.com.

    Media Contact:

    Justine Sessions

    [email protected]

    Investor Relations Contact:

    Ralph Giacobbe

    [email protected]

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/the-cigna-group-announces-leadership-changes-to-continue-driving-growth-302036419.html

    SOURCE The Cigna Group

    Get the next $CI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CI

    DatePrice TargetRatingAnalyst
    2/6/2025$323.00Outperform → Mkt Perform
    Bernstein
    6/26/2024$400.00Overweight
    Piper Sandler
    5/30/2024$388.00Outperform
    Robert W. Baird
    3/6/2024$393.00Overweight
    Barclays
    2/5/2024$334.00 → $372.00Neutral → Overweight
    Cantor Fitzgerald
    2/5/2024$327.00 → $354.00Sector Perform → Outperform
    RBC Capital Mkts
    2/1/2024$355.00 → $370.00Hold → Buy
    Deutsche Bank
    1/4/2024$330.00 → $372.00Mkt Perform → Outperform
    Bernstein
    More analyst ratings

    $CI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Hennigan Michael J was granted 568 shares (SEC Form 4)

      4 - Cigna Group (0001739940) (Issuer)

      6/4/25 4:58:29 PM ET
      $CI
      Medical Specialities
      Health Care
    • SEC Form 3 filed by new insider Hennigan Michael J

      3 - Cigna Group (0001739940) (Issuer)

      6/3/25 5:04:45 PM ET
      $CI
      Medical Specialities
      Health Care
    • SEC Form 4 filed by Director Kurian George

      4 - Cigna Group (0001739940) (Issuer)

      6/3/25 5:04:40 PM ET
      $CI
      Medical Specialities
      Health Care

    $CI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • The Cigna Group downgraded by Bernstein with a new price target

      Bernstein downgraded The Cigna Group from Outperform to Mkt Perform and set a new price target of $323.00

      2/6/25 7:05:01 AM ET
      $CI
      Medical Specialities
      Health Care
    • Piper Sandler initiated coverage on The Cigna Group with a new price target

      Piper Sandler initiated coverage of The Cigna Group with a rating of Overweight and set a new price target of $400.00

      6/26/24 7:28:18 AM ET
      $CI
      Medical Specialities
      Health Care
    • Robert W. Baird initiated coverage on The Cigna Group with a new price target

      Robert W. Baird initiated coverage of The Cigna Group with a rating of Outperform and set a new price target of $388.00

      5/30/24 7:35:19 AM ET
      $CI
      Medical Specialities
      Health Care

    $CI
    SEC Filings

    See more
    • The Cigna Group filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

      8-K - Cigna Group (0001739940) (Filer)

      6/2/25 5:03:47 PM ET
      $CI
      Medical Specialities
      Health Care
    • The Cigna Group filed SEC Form 8-K: Regulation FD Disclosure

      8-K - Cigna Group (0001739940) (Filer)

      5/20/25 6:01:22 AM ET
      $CI
      Medical Specialities
      Health Care
    • SEC Form 144 filed by The Cigna Group

      144 - Cigna Group (0001739940) (Subject)

      5/9/25 4:27:05 PM ET
      $CI
      Medical Specialities
      Health Care